KUALA LUMPUR: Solution Group Bhd
, which has inked a deal with China’s CanSino Biologics Inc for the distribution of the Covid-19 vaccines in Malaysia, has started to plan for bigger things ahead.
The engineering and biopharmaceuticals company is looking to export the vaccines to the South-East Asia region.
However, this plan can only materialise if the group could get approvals from the Health Ministry’s National Pharmaceutical Regulatory Agency (NRPA) for both its vaccine and the fill and finish (F&F) facility plant.
...